|
ATR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.084000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.536560E-03 |
| Normal-vs-Stage2 |
6.153900E-02 |
| Normal-vs-Stage3 |
3.563300E-03 |
| Normal-vs-Stage4 |
2.812800E-01 |
| Stage1-vs-Stage2 |
6.838800E-01 |
| Stage1-vs-Stage3 |
7.379400E-01 |
| Stage1-vs-Stage4 |
1.674560E-01 |
| Stage2-vs-Stage3 |
5.771000E-01 |
| Stage2-vs-Stage4 |
4.649800E-01 |
| Stage3-vs-Stage4 |
1.437040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.761900E-03 |
| Normal-vs-AfricanAmerican |
5.090400E-02 |
| Normal-vs-Asian |
4.761600E-01 |
| Caucasian-vs-AfricanAmerican |
6.896000E-01 |
| Caucasian-vs-Asian |
1.202440E-02 |
| AfricanAmerican-vs-Asian |
1.338640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.224000E-04 |
| Normal-vs-Female |
1.062440E-01 |
| Male-vs-Female |
5.857900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.728600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.303560E-02 |
| Normal-vs-Age(61-80Yrs) |
6.441100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.227980E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.387200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.111800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.971700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.588800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.113870E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.756500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.911400E-01 |
| Normal-vs-Grade 2 |
3.843600E-03 |
| Normal-vs-Grade 3 |
1.816550E-03 |
| Normal-vs-Grade 4 |
2.886800E-01 |
| Grade 1-vs-Grade 2 |
5.428000E-01 |
| Grade 1-vs-Grade 3 |
6.617200E-01 |
| Grade 1-vs-Grade 4 |
7.149400E-01 |
| Grade 2-vs-Grade 3 |
9.632800E-01 |
| Grade 2-vs-Grade 4 |
2.570000E-01 |
| Grade 3-vs-Grade 4 |
2.616600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.359870E-03 |
| Normal-vs-ccB subtype |
9.701800E-02 |
| ccA subtype-vs-ccB subtype |
7.401700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.488200E-02 |
| Normal-vs-N1 |
5.965600E-01 |
| N0-vs-N1 |
2.278800E-01 |
|
|
